2024-12-08 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Investment Report

**1. Performance Summary & Comparison to S&P 500 (VOO):**

Intuitive Surgical Inc. (ISRG) is a company that manufactures and sells da Vinci surgical systems and related instruments.  Over the period analyzed, ISRG significantly outperformed the S&P 500 (VOO).  The cumulative return for ISRG is 303.89%, while the VOO's cumulative return is 122.19%.  This represents a difference of 181.7 percentage points. The relative divergence of 96.5% indicates ISRG's performance is at the high end of its historical performance range relative to the S&P 500.  The provided Alpha values of 0.0 suggest that its performance isn't solely attributable to market-wide movements, although this data needs further context regarding the calculation methodology.

**Alpha, Beta Analysis:** The provided CAGR (Compound Annual Growth Rate) demonstrates strong historical growth, although recent years show some volatility.  The consistently low beta values (around 0.0) initially suggest low correlation with the overall market, but the context for this calculation is needed for a complete interpretation.  High MDD (Maximum Drawdown) figures in some periods warrant attention, indicating significant potential downside risks.

**2. Recent Price Movement:**

* **Closing Price:** $550.41 (Last Market: $550.73)
* **5-Day Moving Average:** $546.51
* **20-Day Moving Average:** $540.70
* **60-Day Moving Average:** $510.31

The price is currently above all three moving averages, suggesting an upward trend.

**3. Technical Indicators & Expected Return:**

* **RSI (Relative Strength Index):** 67.56 – Indicates the stock is in overbought territory, suggesting a potential short-term pullback.
* **PPO (Percentage Price Oscillator):** -0.12 – A negative value suggests bearish momentum.
* **20-Day Relative Divergence Change:** +1.3 – Indicates a recent short-term upward trend.
* **Expected Return:** 103.3% – This represents a significant projected outperformance against the S&P 500 over a long-term horizon (2+ years) based on the available data.  This figure needs further justification and clarification of its calculation. The recent price of $550.73 doesn't indicate a significant sudden jump (no indication of a rapid surge or plunge).

**4. Recent Earnings Analysis:**

The reported EPS and revenue show some volatility.  While revenue has generally increased, the EPS hasn't shown a consistent upward trend.  There's no information provided to compare these results against expectations, preventing any assessment of beats or misses.  Note the duplicated entry for 2024-10-18.

**Revenue Growth Trends:** Revenue growth is generally upward, but not consistently.

**EPS Trends:** EPS fluctuates, not demonstrating a clear, sustained upward trend.

**5. Financial Information Analysis:**

**Revenue and Profitability:** Revenue remains relatively stable, with some quarterly fluctuations. Profit margins are consistently high (above 65%), indicating strong profitability.

**Capital and Profitability:**  Equity has generally increased, but ROE (Return on Equity) shows some variation, suggesting changes in profitability relative to equity levels.  The ROE is lower in recent quarters compared to earlier.


**6. News and Recent Issues:**

* **Recent Earnings News:** The report includes earnings data, but no specific news headlines or announcements about the earnings release within the last two days are provided.
* **Recent Market Outlook & Analyst Opinions:**  No information is provided about recent market outlooks or analyst opinions on ISRG.

**7. Overall Analysis:**

ISRG has demonstrated strong historical outperformance against the S&P 500, with significantly higher cumulative returns.  However, recent performance indicators (RSI, PPO) suggest a potential short-term correction. The high expected return (103.3%) over the long term is promising but requires more details about its calculation and underlying assumptions.  Financial statements reveal consistent profitability and growing equity, although ROE fluctuates.  The lack of news, analyst opinions, and comparison to earnings expectations limits a complete assessment. Further investigation into the provided data's sources and calculations is necessary for a more comprehensive analysis.  The provided alpha and beta values need additional context.  The high maximum drawdown in certain periods highlights substantial risk.


**8. Disclaimer:** This report is based solely on the provided data and does not constitute financial advice.  Conduct thorough independent research and consult a financial advisor before making any investment decisions.  Missing information and potential errors in the given data limit the conclusiveness of this analysis.
